合成和评估Ivacaftor衍生品与降低的脂性
Melissa Iazzi1, Phillip Junor1, Jitesh Doshi2
1Department of Chemistry and Biology, Toronto Metropolitan University, Toronto, Ontario M5B 2K3, Canada.
研究人员开发了 ivacaftor 的新型,低脂肪版本,以改善囊性纤维化 (CF) 治疗. 一种衍生品,化合物3,有效地恢复了CFTR通道功能,而不降低细胞表面蛋白质水平,与原始药物不同.
科学领域:
- 生物化学和分子生物学
- 药理学 药理学是指药理学的学科.
- 遗传学 是一个遗传学.
背景情况:
- 囊性纤维化 (CF) 是由囊性纤维化导电性调节器 (CFTR) 基因的突变引起的.
- 伊瓦卡夫托是针对特定CF突变批准的CFTR增强剂,但可以破坏其他CFTR变异的稳定,并降低组合疗法的有效性.
研究的目的:
- 调查 ivacaftor 的高脂性是否有助于其在某些 CFTR 突变环境中的负面影响.
- 合成和评估具有降低脂友性和提高CFTR强化功效的新型ivacaftor衍生物.
主要方法:
- 合成三种谷氨酸 ivacaftor衍生物 (化合物2,3,4) 具有不同的脂性和电荷.
- 使用细胞离子流量试验评估CFTR通道活性.
- 对折叠救援的细胞表面水平的复合效应的评估 ΔF508-CFTR.
- 分子建模以预测CFTR蛋白内的结合相互作用.
主要成果:
- 所有合成的衍生品都恢复了G551D-CFTR通道活性,效果与ivacaftor相比或更高.
- 化合物3与 ivacaftor 不同,它没有降低折叠救援的 ΔF508-CFTR 的细胞表面水平.
- 分子建模表明,化合物3的极性增加促进了CFTR结合口袋中更强的极性和离子相互作用.
结论:
- 减少ivacaftor衍生物的脂性可能会提高它们作为CFTR增强剂的有效性,特别是对于折叠救援的ΔF508-CFTR.
- 化合物3显示出作为更有效和更安全的CFTR增强剂的潜力,解决了当前基于ivacaftor的治疗方法的局限性.
更多相关视频
06:34Synthesis of Antiviral Tetrahydrocarbazole Derivatives by Photochemical and Acid-catalyzed C-H Functionalization via Intermediate Peroxides CHIPS
Published on: June 20, 2014
08:44Preparation, Administration, and Assessment of In Vivo Tissue-Specific Cellular Uptake of Fluorescent Dye-Labeled Liposomes
Published on: July 30, 2020
相关概念视频
Carboxylic Acid Derivatives: Overview
Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Relative Reactivity of Carboxylic Acid Derivatives
A key factor in assessing the reactivity of the acid derivatives is the basicity of the substituent or the leaving group. The lower the basicity of the leaving group, the higher the reactivity of the derivative. The basicity of the leaving group follows this order:
Halide ions < Acyloxy ions < Alkoxy ions < Amine ions
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
